Airway epithelial mucus production

Airway epithelial mucus production refers to the synthesis and regulated secretion of gel-forming mucins (primarily MUC5AC and MUC5B) by goblet cells and submucosal gland cells in the respiratory epithelium. These mucins are large, heavily glycosylated polymers that, upon secretion and hydration, form a viscoelastic mucus layer. This layer traps inhaled particles, pathogens, and irritants, which are then cleared from the lungs by ciliary action (mucociliary clearance). Mucus production and secretion are tightly regulated processes, with low baseline rates maintaining steady-state clearance and high stimulated rates responding to irritants or inflammation. The process involves intracellular mucin synthesis, granule formation, regulated exocytosis, and rapid hydration post-secretion. Proper mucus hydration and viscosity are critical for effective clearance; dysregulation (e.g., in cystic fibrosis) results in abnormally thick, sticky mucus that obstructs airways and promotes infection. While "airway epithelial mucus production" describes a biological process rather than a single molecule or receptor, key molecular players include the mucins MUC5AC and MUC5B, ion channels such as CFTR (cystic fibrosis transmembrane conductance regulator) and ENaC (epithelial sodium channel) that regulate mucus hydration, and signaling molecules like ATP, adenosine, and various cytokines that modulate mucin secretion and hydration[1][2][4]. This process is a therapeutic target in diseases characterized by mucus hypersecretion or poor clearance, though direct pharmacological modulation typically focuses on individual molecular components (e.g., mucins, ion channels) rather than the process as a whole.